Ownership history in TSFG, LLC · 21 quarters on record
This page tracks every 13F SEC filing in which TSFG, LLC reported a position in SAREPTA THERAPEUTICS (SRPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 1,260 | +1,210 | +2420.0% | 0.00% | $24K | $19.27 |
| 2024 Q3 | REDUCED | 50 | -75 | -60.0% | 0.00% | $6K | $124.89 |
| 2024 Q2 | REDUCED | 125 | -35 | -21.9% | 0.00% | $20K | $158.00 |
| 2024 Q1 | UNCHANGED | 160 | — | 0% | 0.01% | $21K | $129.46 |
| 2023 Q4 | UNCHANGED | 160 | — | 0% | 0.00% | $15K | $96.43 |
| 2023 Q3 | REDUCED | 160 | -95 | -37.3% | 0.01% | $19K | $121.22 |
| 2023 Q2 | UNCHANGED | 255 | — | 0% | 0.01% | $29K | $114.52 |
| 2023 Q1 | UNCHANGED | 255 | — | 0% | 0.01% | $35K | $137.83 |
| 2022 Q4 | UNCHANGED | 255 | — | 0% | 0.01% | $33K | $129.58 |
| 2022 Q3 | UNCHANGED | 255 | — | 0% | 0.01% | $28K | $110.54 |
As of 2025 Q4 — sorted by position size